Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19571210 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHRTP53HBB | |
| SCHEMBL1161648 | 0.87 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRTP53HBB | |
| SCHEMBL15358742 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TDP1TSHR | |
| SCHEMBL11104322 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TDP1 | |
| SCHEMBL9821364 | 0.86 | ALDH1A1 (0.33) | ALDH1A1TDP1TSHRTP53 | |
| SCHEMBL17356546 | 0.82 | ALDH1A1 (0.35) | ALDH1A1TDP1TSHR | |
| SCHEMBL11317466 | 0.82 | ALDH1A1 (0.37) | ALDH1A1TDP1TSHRSMN1; SMN2MEN1 | |
| SCHEMBL11715962 | 0.82 | ALDH1A1 (0.35) | ALDH1A1TDP1TSHR | |
| SCHEMBL11317474 | 0.82 | ALDH1A1 (0.37) | ALDH1A1TDP1TSHRSMN1; SMN2MEN1 | |
| SCHEMBL2754956 | 0.82 | ALDH1A1 (0.31) | ALDH1A1TDP1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10865278-B2 | Vesicles formed from block copolymers, and novel block copolymers | APPLIED BIOMIMETIC A/S (DK) | 2020-12-15 | — | — | US | disclosed |
| EP-3141633-B1 | COPPER PLATING BATH COMPOSITION | ATOTECH DEUTSCHLAND GMBH (DE) | 2018-05-02 | — | — | EP | disclosed |
| US-20180079869-A1 | VESICLES FORMED FROM BLOCK COPOLYMERS, AND NOVEL BLOCK COPOLYMERS | APPLIED BIOMIMETIC A/S (DK) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079869-A1 | VESICLES FORMED FROM BLOCK COPOLYMERS, AND NOVEL BLOCK COPOLYMERS | CHMP4B, EXOSC10, VAMP7 | ALDH1A1 2181/4885TDP1 1657/4885TSHR 4799/4885 |
| US-10865278-B2 | Vesicles formed from block copolymers, and novel block copolymers | CHMP4B, EXOSC10, VAMP7 | ALDH1A1 2181/4885TDP1 1657/4885TSHR 4799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.